BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 21878663)

  • 1. Polyphenols, isothiocyanates, and carotenoid derivatives enhance estrogenic activity in bone cells but inhibit it in breast cancer cells.
    Veprik A; Khanin M; Linnewiel-Hermoni K; Danilenko M; Levy J; Sharoni Y
    Am J Physiol Endocrinol Metab; 2012 Oct; 303(7):E815-24. PubMed ID: 21878663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lycopene and other carotenoids inhibit estrogenic activity of 17beta-estradiol and genistein in cancer cells.
    Hirsch K; Atzmon A; Danilenko M; Levy J; Sharoni Y
    Breast Cancer Res Treat; 2007 Aug; 104(2):221-30. PubMed ID: 17051425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential use of an estrogen-glucocorticoid receptor chimera as a drug screen for tissue selective estrogenic activity.
    Maru BS; Tobias JH; Rivers C; Caunt CJ; Norman MR; McArdle CA
    Bone; 2009 Jan; 44(1):102-12. PubMed ID: 18976723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure activity relationship of carotenoid derivatives in activation of the electrophile/antioxidant response element transcription system.
    Linnewiel K; Ernst H; Caris-Veyrat C; Ben-Dor A; Kampf A; Salman H; Danilenko M; Levy J; Sharoni Y
    Free Radic Biol Med; 2009 Sep; 47(5):659-67. PubMed ID: 19524036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
    Menendez JA; Oza BP; Colomer R; Lupu R
    Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LC, a novel estrone-rhein hybrid compound, concurrently stimulates osteoprotegerin and inhibits receptor activator of NF-κB ligand (RANKL) and interleukin-6 production by human osteoblastic cells.
    Wang Y; Li LZ; Zhang YL; Zhu YQ; Wu J; Sun WJ
    Mol Cell Endocrinol; 2011 Apr; 337(1-2):43-51. PubMed ID: 21291955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of tumor-associated fatty acid synthase activity antagonizes estradiol- and tamoxifen-induced agonist transactivation of estrogen receptor (ER) in human endometrial adenocarcinoma cells.
    Menendez JA; Oza BP; Atlas E; Verma VA; Mehmi I; Lupu R
    Oncogene; 2004 Jun; 23(28):4945-58. PubMed ID: 15094777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen receptor alpha and beta subtype expression and transactivation capacity are differentially affected by receptor-, hsp90- and immunophilin-ligands in human breast cancer cells.
    Gougelet A; Bouclier C; Marsaud V; Maillard S; Mueller SO; Korach KS; Renoir JM
    J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):71-81. PubMed ID: 15862952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A trans-acting enhancer modulates estrogen-mediated transcription of reporter genes in osteoblasts.
    Sasaki-Iwaoka H; Maruyama K; Endoh H; Komori T; Kato S; Kawashima H
    J Bone Miner Res; 1999 Feb; 14(2):248-55. PubMed ID: 9933479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
    Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance.
    Imachi H; Murao K; Dobashi H; Bhuyan MM; Cao X; Kontani K; Niki S; Murazawa C; Nakajima H; Kohno N; Yamashita H; Iwase H; Hayashi S; Ishida T; Yamauchi A
    Breast Cancer Res Treat; 2010 Jul; 122(2):395-407. PubMed ID: 19847644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-estrogenic effect of unliganded progesterone receptor is estrogen-selective in breast cancer cells MCF-7.
    Zheng ZY; Lin VC
    Cancer Lett; 2008 Sep; 268(2):202-11. PubMed ID: 18477500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NF-kappaB and estrogen receptor alpha interactions: Differential function in estrogen receptor-negative and -positive hormone-independent breast cancer cells.
    Gionet N; Jansson D; Mader S; Pratt MA
    J Cell Biochem; 2009 Jun; 107(3):448-59. PubMed ID: 19350539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin inhibits both ER alpha activation and breast cancer cell proliferation induced by a metalloestrogen, cadmium.
    Martínez-Campa C; Alonso-González C; Mediavilla MD; Cos S; González A; Ramos S; Sánchez-Barceló EJ
    J Pineal Res; 2006 May; 40(4):291-6. PubMed ID: 16635015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phytoestrogens activate estrogen receptor beta1 and estrogenic responses in human breast and bone cancer cell lines.
    Chrzan BG; Bradford PG
    Mol Nutr Food Res; 2007 Feb; 51(2):171-7. PubMed ID: 17266178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretory products of breast cancer cells specifically affect human osteoblastic cells: partial characterization of active factors.
    Siwek B; Lacroix M; De Pollak C; Marie P; Body JJ
    J Bone Miner Res; 1997 Apr; 12(4):552-60. PubMed ID: 9101366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of estrogenic/antiestrogenic activity of ellagic acid via the estrogen receptor subtypes ERalpha and ERbeta.
    Papoutsi Z; Kassi E; Tsiapara A; Fokialakis N; Chrousos GP; Moutsatsou P
    J Agric Food Chem; 2005 Oct; 53(20):7715-20. PubMed ID: 16190622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of bone morphogenetic protein-6 gene transcription in MCF-7 cells by estrogen.
    Zhang M; Yan JD; Zhang L; Wang Q; Lü SJ; Zhang J; Zhu TH
    Chin Med J (Engl); 2005 Oct; 118(19):1629-36. PubMed ID: 16232348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling.
    Jiang J; Slivova V; Sliva D
    Int J Oncol; 2006 Sep; 29(3):695-703. PubMed ID: 16865287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation and characterization of a human osteosarcoma cell line stably transfected with the human estrogen receptor gene.
    Huo B; Dossing DA; Dimuzio MT
    J Bone Miner Res; 1995 May; 10(5):769-81. PubMed ID: 7639112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.